Treat to Target # 2 – Fragility Fracture

Treat to Target means aiming for NO NEW FRACTURES.  As discussed last time, the original target was to maintain Bone Mineral Density (BMD) at the level first tested.  25 years...

A New Anabolic – Tymlos

The FDA approved Tymlos (Abaloparatide) in June for use in women diagnosed with osteoporosis.  Unfortunately most patients are unlikely to obtain insurance coverage for Tymlos until January or February 2018. Tymlos...

“Treat to Target” and “Use VFA” in 2017

Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year.  Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric.  Several speakers emphasizd...

NOF & ISCD at “Clinical Osteoporosis 2017”

The National Osteoporosis Foundation (NOF) and the International Society for Clinical Densitometry (ISCD) are meeting together later this week.  This will be my 10th attendance at each group.  They are...

Diabetes + High BMD = Brittle Bone

Patients with poorly controlled Diabetes and high blood sugar levels often have bone with above average Bone Mineral Density (BMD).  This is good?  WRONG !! High blood sugars lead to...

Stronger, More Agile, More Confident

Ann spends a week in Florida each winter with several friends and was stronger, more agile and more confident this year than last.  She stepped in and out of the hot-tub...

ISCD 2015

Driving to Chicago in February was cold and snowing.  But it was hot indoors at the ISCD (International Society for Clinical Densitometry) Annual Meeting and Position Development Conference (PDC). While...

Not Just DXA – Fracture Risk !!

DXA is very good at determining Bone Mineral Density (BMD), provided you look at the images and over-read the computer.  DXA alone is less good at predicting Fracture Risk.  But,...

Birthday Disease

“Why did I Fracture?” and “Why do I have Osteoporosis?” are common questions I hear from older women and men.  They are taking Calcium and Vitamin D3, eating a diet...